EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation

Zuguo Liang, Chuanwang Sun, Zichen Tian, Hang Su, Xiangyan Li

Pharmaceuticals · 19.11.2026 · 19 (11) · 1846

DOI: 10.3390/ph19111846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.11.2026. Verfasst von Zuguo Liang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sodium-glucose cotransporter 2 (SGLT2) plays a critical role in renal tubular glucose reabsorption in diabetic kidney disease (DKD). This study aimed to simulate the in vitro digestion process to obtain enzymatic hydrolysates of leeches, establish a peptide profile library of leech-derived peptides, and specifically identify potential SGLT2-interacting peptide candidates originating from leeches.

Methods

Response surface methodology was employed to optimize the simulated in vitro gastrointestinal digestion process of leech proteins. A leech-derived peptide library was constructed via nano-flow liquid chromatography tandem mass spectrometry. Multi-level screening of leech peptides was completed through bioactivity scoring, absorption and toxicity prediction. Subsequently, Boltz-2 was used for virtual screening against human SGLT2 (PDB: 7VSI), followed by all-atom interaction and binding-affinity analyses. Finally, we synthesized the candidate peptides and performed experimental validation in the HK-2 cell model using cellular thermal shift assay, Western blot, and flow cytometry analysis.

Results

After optimized enzymatic digestion, a total of 8816 leech-derived peptide sequences were identified, and 14 high-confidence candidate peptides were obtained by screening. Among them, PVIFPVPR, ANALPHFP, and PFIPPNKL achieved ipTM scores greater than 0.8. PVIFPVPR binds to the TM4 region of SGLT2 mainly through hydrophobic interactions and hydrogen bonds. Furthermore, this peptide exhibits excellent capacity to improve the thermal stability of SGLT2. It also down-regulated the expression of SGLT2 and N-cadherin, restored E-cadherin levels, and reduced excessive glucose uptake in HK-2 cells.

Conclusions

The leech-derived peptide PVIFPVPR is a potential SGLT2-interacting candidate and was associated with attenuated fibrosis and aberrant glucose uptake in HK-2 cells. This novel leech derived peptide represents a candidate peptide with potential relevance to SGLT2 associated pathways for further preclinical investigation of DKD-related tubular injury.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Liang, Z., Sun, C., Tian, Z., Su, H., & Li, X. (2026). Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation. Pharmaceuticals, 19(11), 1846. https://doi.org/10.3390/ph19111846

Vancouver

Liang Z, Sun C, Tian Z, Su H, Li X. Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation. Pharmaceuticals. 2026;19(11):1846. doi:10.3390/ph19111846

BibTeX
@article{Liang2026,
  author = {Liang, Zuguo and Sun, Chuanwang and Tian, Zichen and Su, Hang and Li, Xiangyan},
  title = {Identification of Novel Peptides from Leech as Potential SGLT2 Inhibitors by Virtual Screening and Cell-Based Experimental Validation},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1846},
  doi = {10.3390/ph19111846}
}
Kostenlos starten →